Oral News and Research

RSS

First-of-its-kind cardiovascular drug gets FDA approval based on study from Canadian VIGOUR Centre

The U.S. Food and Drug Administration has approved the drug vericiguat for use in patients with heart failure.

25 Jan 2021

New, highly accurate 20-minute COVID-19 test is trialed across the University of Surrey

A new, highly accurate COVID-19 test, Virus Hunter 6 (VH6), which delivers results in under 20 minutes is being trialed across the University of Surrey, this week.

25 Jan 2021

New maintenance treatment for AML shows strong benefit for patients

Patients with acute myeloid leukemia (AML), the most common form of acute leukemia in adults, that has gone into remission following initial chemotherapy remain in remission longer and have improved overall survival when they are given a pill form of the cancer drug azacitidine as a maintenance treatment, according to a randomized, international phase 3 clinical trial for which Weill Cornell Medicine and NewYork-Presbyterian are trial sites.

22 Jan 2021

New pain management regimen reduced opioid exposure in trauma patients

A pain management regimen comprised mostly of over-the-counter medication reduced opioid exposure in trauma patients while achieving equal levels of pain control, according to a new study by physician-researchers at The University of Texas Health Science Center at Houston (UTHealth).

22 Jan 2021

FDA approves first injectable, complete regimen for HIV-1 infection in adults

The U.S. Food and Drug Administration today approved Cabenuva (cabotegravir and rilpivirine, injectable formulation) as a complete regimen for the treatment of human immunodeficiency virus type 1 (HIV-1) infection in adults to replace a current antiretroviral regimen in those who are virologically suppressed on a stable antiretroviral regimen with no history of treatment failure and with no known or suspected resistance to either cabotegravir or rilpivirine.

21 Jan 2021

SU2C announces $3.25 million in grants to find new treatments for head and neck cancers

Stand Up To Cancer today announced $3.25 million in grants from four national nonprofits to fund research to find new treatments for head and neck cancers, which are newly diagnosed in about 65,000 Americans every year.

21 Jan 2021

Multimodal pain regimen minimizes opioid exposure, relieves acute pain in trauma patients

A multimodal pain regimen (MMPR) designed to minimize opioid exposure and relieve acute pain associated with traumatic injury kept patient self-reported pain scores low while also reducing the daily and total amount of opioid drugs given to trauma patients.

21 Jan 2021

ACE2 and furin levels linked to inflammation in smokers with COVID-19

A new study reports the level of ACE2 and furin, two enzymes that are intimately linked to infection with SARS-CoV-2, the causative agent of COVID-19.

21 Jan 2021

Fecal microbiome and metabolome vary in healthy and food-allergic twins, shows study

A new study out of the University of Chicago and Stanford University on pairs of twins with and without food allergies has identified potential microbial players in this condition.

19 Jan 2021

Could procalcitonin indicate bacterial co-infections in COVID-19 patients?

A recent study conducted by Austin Health, Australia, has revealed that the serum level of procalcitonin can be a strong indicator of bacterial co-infection with COVID-19.

18 Jan 2021

New nasal spray delivers antipsychotic medication directly to the brain

A team of neuroscientists and engineers at McMaster University has created a nasal spray to deliver antipsychotic medication directly to the brain instead of having it pass through the body.

16 Jan 2021

Study: NTRK fusions are far more frequently seen in pediatric tumors

In a large study of pediatric cancer patients, researchers from Children's Hospital of Philadelphia have analyzed the frequency, fusion partners, and clinical outcome of neurotrophic tyrosine receptor kinase (NTRK) fusions, which are clinical biomarkers that identify patients suitable for treatment with FDA-approved TRK inhibitors.

16 Jan 2021

Geography is destiny: Dentists’ access to Covid shots depends on where they live

Dr. Monte Junker, an Oregon dentist, is waiting for his turn to get vaccinated for Covid even though he considers himself a front-line health worker.

15 Jan 2021

Study reveals connection between oral sex and oropharyngeal cancer

A wide breadth of behaviors surrounding oral sex may affect the risk of oral HPV infection and of a virus-associated head and neck cancer that can be spread through this route, a new study led by researchers at the Johns Hopkins Kimmel Cancer Center suggests.

15 Jan 2021

Certain oral pathogens are more prevalent in esophageal cancer patients

Researchers led by Tokyo Medical and Dental University (TMDU) find that certain oral pathogens are more prevalent in esophageal cancer patients, and could be used as a novel diagnostic tool.

14 Jan 2021

Researchers receive $5.1 million to expand clinical trial of drug to prevent ARDS in COVID-19 patients

Researchers evaluating whether an investigational oral drug, vadadustat, can help prevent acute respiratory distress s to expand the Phase II clinical trial at The University of Texas Health Science Center at HoustonQ.

13 Jan 2021

Scientists identify key enzyme as driver of autoimmune blistering diseases

The Granzyme B (GzmB) enzyme, which accumulates in certain tissues as we age, has been identified as a driver of itchy and sometimes life-threatening autoimmune conditions known as pemphigoid diseases (PDs), which cause blistering and skin erosion below the skin's surface.

13 Jan 2021

Oral News and Research

First-of-its-kind cardiovascular drug gets FDA approval based on study from Canadian VIGOUR Centre

New, highly accurate 20-minute COVID-19 test is trialed across the University of Surrey

New maintenance treatment for AML shows strong benefit for patients

New pain management regimen reduced opioid exposure in trauma patients

FDA approves first injectable, complete regimen for HIV-1 infection in adults

SU2C announces $3.25 million in grants to find new treatments for head and neck cancers

Multimodal pain regimen minimizes opioid exposure, relieves acute pain in trauma patients

ACE2 and furin levels linked to inflammation in smokers with COVID-19

Fecal microbiome and metabolome vary in healthy and food-allergic twins, shows study

Could procalcitonin indicate bacterial co-infections in COVID-19 patients?

New nasal spray delivers antipsychotic medication directly to the brain

Study: NTRK fusions are far more frequently seen in pediatric tumors

Geography is destiny: Dentists’ access to Covid shots depends on where they live

Study reveals connection between oral sex and oropharyngeal cancer

Certain oral pathogens are more prevalent in esophageal cancer patients

Researchers receive $5.1 million to expand clinical trial of drug to prevent ARDS in COVID-19 patients

Scientists identify key enzyme as driver of autoimmune blistering diseases

Researchers call for stronger regulations to reduce health burden of smokeless tobacco

Insulin nanoparticles may become an alternative to insulin injections for diabetic patients

Study could help develop new oral drugs for treating muscular dystrophy, heart failure

Advancing Intracellular Delivery with LumiPore®

How ELRIG Is Helping Mid-Career Scientists Navigate Leadership, Career Change and Redundancy

The role of UV-Vis in biopharma QC

Latest News